Mst1/2 signalling to Yap: gatekeeper for liver size and tumour development
2011

Mst1/2 Signalling to Yap: Gatekeeper for Liver Size and Tumour Development

publication Evidence: high

Author Information

Author(s): Avruch J, Zhou D, Fitamant J, Bardeesy N

Primary Institution: Massachusetts General Hospital

Hypothesis

The study investigates the role of Mst1/2 signalling in regulating liver size and its implications for tumor development.

Conclusion

Mst1 and Mst2 function as critical tumor suppressors in the liver, and their inactivation leads to liver overgrowth and cancer.

Supporting Evidence

  • The Hippo signalling pathway is crucial for liver growth control.
  • Defects in Mst1/2 lead to liver overgrowth and cancer.
  • Yap is identified as an oncogene in liver cancer.
  • Studies show that Mst1 and Mst2 are essential for maintaining hepatocyte quiescence.

Takeaway

This study shows that certain proteins help control how big the liver can grow, and when these proteins don't work right, it can lead to liver cancer.

Methodology

The study reviews recent findings on the Hippo signalling pathway and its components in liver biology and cancer.

Digital Object Identifier (DOI)

10.1038/sj.bjc.6606011

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication